Showing results (111-120 of 1,226) with videos related to

Sort By:
Pageof 123
Annals of the New York Academy of Sciences|September 26, 2007
Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndromeI Krause, M Blank, R Cervera, et al.
Lupus|September 4, 2010
The embryotoxicity of sera from patients with autoimmune diseases on post-implantation rat embryos in culture persists during remission and is not related to oxidative stressZ Ergaz, D Mevorach, G Goldzweig, et al.
Clinical and Experimental Immunology|October 23, 2010
Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgarisD Mimouni, M Blank, A S Payne, et al.
Lupus|June 1, 1995
Antiphospholipid syndrome and the idiotypic networkR Bakimer, M Blank, D Kosashvilli, et al.
Annals of the Rheumatic Diseases|March 22, 2005
Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndromeI Krause, S Lev, A Fraser, et al.
Arthritis and Rheumatism|March 4, 1998
Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expressionM Blank, J George, P Fishman, et al.
Journal of Autoimmunity|October 23, 2009
Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosisV Barak, C Selmi, M Schlesinger, et al.
Israel Journal of Medical Sciences|July 1, 1996
Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma)Y Shoenfeld, E Grunebaum, M Laufer, et al.
Clinical and Experimental Immunology|May 1, 1997
Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS)J George, M Blank, M Hojnik, et al.
Immunologic Research|September 14, 2016
Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposureO Shovman, B Gilburd, C Chayat, et al.
Pageof 123